Myhep All tablets (Epclusa): Sofosbuvir 400 mg and Velpatasvir 100 mg Course 12 weeks instructions for use
Ideal for the treatment of all genotypes of the hepatitis C virus, a course of treatment even with cirrhosis for 12 weeks.
Order Epclusa tablets in India with us, and get a discount! Learn more by phone.
There is no vaccine against hepatitis C due to the strong mutation of the virus causing this disease. If you do not pay attention, Myhep All hepatitis will become chronic, leading to liver failure. To combat the disease requires treatment with effective modern drugs. And such a drug is Epclusa. It allows you to get a positive effect from treatment in 95% of cases.
This is an innovative cure for the biopharmaceutical company Gilead Sciences, Inc. You can purchase it with the help of our company. By request we will deliver it, in Russia Epclusa is not made.
Detailed description
Epclusa is a breakthrough in the treatment of chronic Hepatitis C. Its effectiveness has been revealed in relation to 6 major genotypes of the Hepatitis C virus. It is produced in tablet form, which includes both active components and auxiliary components that improve the absorption of the drug.

Among the current:
- Sofosbuvir 400mg: which suppresses the activity of the NS5B polymerase, which is the causative agent of the disease;
- Velpatasvir 100 mg: is a blocker of the non-structural NS5A protein of the hepatitis C virus.
- Auxiliary: copovidone, magnesium stearate, silicon dioxide, lactose monohydrate, cellulose elements.
- The glossy shell of the tablet contains polyethylene glycol, titanium dioxide, iron oxide, talc.
Indications for use
The drug is recommended for patients for the treatment of hepatitis C, including those who suffer from the chronic form of the disease with a complication in the form of compensated or decompensated liver cirrhosis.
Patients with genotypes 2 and 3 can take Velpatasvir Epclusa without Ribavirin, a broad-spectrum antiviral drug.
Contraindications
Due to the content in the composition of the drug Velpatasvir, it is strictly forbidden to use Epclusa in patients with severe bradycardia.
In addition, therapy in combination with Amiodarone is not acceptable. This ligament leads to severe bradycardia, which is fatal.
Side effects
Despite the fact that the drug is well tolerated by the majority of patients, but in some cases, as shown by testing and patient reviews confirmed this, it causes side effects, expressed as
- general weakness;
- severe fatigue;
- headache.
The frequency of side effects was particularly increased in patients with a low heart rate who were taking the antiarrhythmic drug Cordarone.
Reception features
The course of treatment with oral Epclusa Cost in India is 12 weeks, regardless of whether the patient received antiviral therapy or started treatment for the first time. The recommended dose is 1 tablet / day, preferably at the same time. Eating does not affect the quality of absorption of the drug.
Patients with Hepatitis C, which is complicated by cirrhosis of the liver, are recommended to take a double course of treatment at a time.
Storage conditions
Special conditions for storage of the drug does not require. The main thing is that the tablets should be in intact packaging, in a dry place inaccessible to children, at a temperature not exceeding 30 ° C.
Recently, people are faced with counterfeit medicines and, instead of treatment, they get complications during the course of the disease. We are engaged in the delivery of Epclusa, the certificate of which confirms the original origin of the medicine.